Neal McCall, MD

I am thrilled to announce that we have treated our first SCINTIX patient on the @reflexionmed X1 in #radonc @UPMCHillmanCC. This represents one of the first patients in the world to be treated using this tracer guided delivery of #radiation to treat cancer and the culmination of the tireless efforts of our amazing staff. As we develop this technique through clinical experience, #clinicaltrials, and expansion of #radiotracers, it will provide substantial benefit to patients and open up additional avenues of our understanding of tumor response and radiation delivery.

Black patients remain underrepresented in clinical trials. This real-world study examines the impact of race in patients with NSCLC treated with chemoradiation and durvalumab. 🔗acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… @OncoAlert #LCSM

Beyond excited and grateful for the opportunity to join @UPMCHillmanCC and make it back the the ‘Burgh later this year! @HSkinnerMDPhD